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Abstract  
AIM: The aim was to investigate serum vitamin D (25-OH) level among females with 
hypothyroidism. 
MATERIALS AND METHODS: A case-control study (58 in each arm) was conducted in Arar 
Central Hospital, Kingdom Saudi Arabia. The cases were females with hypothyroidism, and healthy 
females were controls. TSH, thyroid hormones: Free T3 (FT3) and Free T4 (FT4) and haemoglobin 
levels were measured in all participants. Serum vitamin D (25-OH) level was measured using the 
spectrophotometry.
 
RESULTS: While there was no significant difference in the age and haemoglobin level, body mass 
index (BMI) was significantly higher in the cases. Compared with the controls, cases had 
significantly higher TSH, had significantly lower T4, and there was no significant difference in FT3 
and 25 (OH) vitamin D, [16.1 (8.8-26.7) vs. 14.0 (9.5-20.3 ng/ml; P = 0.577]. Linear regression 
showed no association between, age, BMI, haemoglobin, TSH, FT3, FT4 and the log of 25 (OH) 
vitamin D levels.  
CONCLUSION: There was no significant difference in vitamin D level among females with 
hypothyroidism and healthy controls. 
 
 
 
 
Introduction 
 
Vitamin D deficiency is a global health 
problem where over a billion people worldwide have 
some vitamin D deficiency or insufficiency [1, 2]. The 
essential biological action of vitamin D is the 
regulation of calcium and phosphorus metabolism. 
Though the role of vitamin D in the regulation of 
immune system has recently been reported [3, 4]. 
Hypothyroidism is a common disease in the general 
population, most of which results as consequences of 
Hashimoto's thyroiditis with a tendency to increase 
with age and female are at 8 to 15 times at higher risk 
than men [5]. It has been observed that serum Vitamin 
D3 metabolites are elevated in hypothyroid subjects 
[6]. 
 
However, a reduced level has been reported 
in a patient with over-active thyroid gland [7]. Thyroid 
disorders may affect vitamin D status as subnormal 
levels of vitamin D were observed in a patient with 
Graves' disease [8]. The role of vitamin D is explored 
as an anti-inflammatory, anti-proliferative factor and 
association with many clinical disorders [9, 10]. 
Vitamin D has a direct and indirect role in inhibiting 
the production of cytokines (IL-12 and IFN-c), hence, 
enhances the immune and anti-inflammatory 
responses [11]. 
 
Vitamin D is circulating in the blood attached 
to a D-binding protein. Then hydroxylation takes place 
at the liver and the kidneys to produce 25(OH) D and 
the active metabolite, 1, 25 dihydroxy vitamin D (1, 
25-(OH) 2 D) respectively [12]. The active form of 
vitamin D is called calcitriol or 1, 25-dihydroxyvitamin 
D3. Serum 25(OH) D is used to reflect vitamin D 
status because it is the major circulating precursor of 
active vitamin D and has a half-life, ranging from two 
to three weeks.  
Interestingly, 1, 25-(OH) vitamin D has a short 
circulating half-life and is tightly under the influence of 
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parathyroid hormone, calcium and phosphate [13]. 
Moreover, low level of serum 1, 25-(OH) 2D may not 
observe until vitamin D deficiency is severe [14]. 
Hence 25(OH) level is used to assess vitamin D 
reserve. Vitamin D has a vital role in many 
physiological actions and an association with some 
clinical disorders.  
Hence the current study was conducted to 
investigate serum vitamin D (25-OH) level among 
Saudi females with hypothyroidism.  
 
 
Material and Methods 
 
A case- control study was conducted at Arar 
Central Hospital, Kingdom of Saudi Arabia during the 
period 1st of November 2014 to 1st of May 2015. 
Cases were women with hypothyroidism. Moreover, 
those who had symptoms suggestive of 
hypothyroidism e.g. fatigue, cold intolerance, 
constipation, weight gain, dry skin and menstrual 
disturbance or those who had sounding features: 
puffy, hoarseness, depressed mood and bradycardia 
were screened and enrolled as new cases if proofed 
to have hypothyroidism. The cases were diagnosed 
by the high level of TSH (≥ 6.30 miU/L) with lower 
levels of FT3 and FT4 than normal value. The controls 
were healthy females. Those with chronic medical 
diseases, on vitamin D supplementation, children, 
pregnant females and non-Saudi citizen, were 
excluded.  
Ethical approval was obtained from medical 
education and research centre at Arar Central 
Hospital, KSA. 
After signing an informed consent, height and 
weight were measured using the conventional method 
and were used to calculate the body mass index (BMI) 
by using the formula: weight in kilogrammes (kg) 
divided by height in square meters (m^2). 
Blood (5 ml) was withdrawn, kept for 30 
minutes at the room temperature to clot and 
centrifuged for five minutes. Then TSH, FT3 and FT4 
were measured using commercially available kits 
(Roche Diagnostics, Mannheim, Germany). Reference 
values for normal range of TSH (0.48 – 6.30 mU/l), 
FT3 (3.39-5.82, pmol/l) and FT4 (9.00-17.15, pmol/l) 
[15]. 
The 25-hydroxy vitamin D (25 (OH) vitamin D) 
was measured using spectrophotometry. The normal 
level of 25 (OH) D is 30 ng/ml or above [16]. 
Haemoglobin (Hb) level was checked too. 
Fifty-eight participants in each arm of the 
study were calculated as to have the difference in the 
mean level of thyroid hormones and 25 (OH) vitamin 
D between the two groups and to have over 80% 
power to detect a difference of 5% at α = 0.05. We 
assumed that 10% of participants might not respond 
or have incomplete data. 
 
Statistical analysis 
Data was analysed using the Statistical 
Package for the Social Sciences (SPSS) version 22 
(Chicago, IL, USA). Chi-square test was used to 
compare proportions between the two groups. 
Kolmogorov –Smirnov test was used for testing the 
normality of the data. Student’s t-test and Mann-
Whitney test were used to compare the continuous 
parametric and non-parametric (thyroid hormones and 
25 (OH) vitamin D) data, respectively between the two 
groups. Simple linear regression models with the log 
of 25 (OH) vitamin D as a continuous dependent 
variable was used. Socio-demographic character-
critics, BMI, and thyroid hormones levels were the 
independent predictors of interest. A p value of <0.05 
was considered significant.
 
 
 
Results 
 
While there was no significant difference in 
the mean (SD) of age [34.1 (13.2)] vs. [37.3 (10.2) 
years, P =0.140] and haemoglobin [12.2 (1.4) vs. 12.6 
(1.4) g/dl, P= 0.192] levels between the two groups, 
BMI was significantly higher in the cases compared 
with the controls, [33.2 (6.2) vs. 30.2 (6.1, kg/m^2, 
P=0.01], Table 1. 
Table 1: Comparing the mean (SD) of the age, body mass index 
and haemoglobin level between the cases and the controls 
Variables  Cases (n = 58) Control (n = 58) P 
Age, years 34.1 (13.2) 37.3 (10.2) 0.140 
Body mass index, k/m^2 33.2 (6.2) 30.2 (6.1) 0.010 
Haemoglobin, g/dl 12.2 (1.4) 12.6 (1.4) 0.192 
 
Compared with the controls, cases had 
significantly higher TSH, had significantly lower FT4, 
and there was no significant difference in FT3 (4.7 
(3.8 -5.4) vs. 4.5 (3.9 ─ 5.3) pmol/l, P=0.685) and 25 
(OH) vitamin D, 16.1(8.8─ 26.7) vs. 14.0 (9.5─ 
20.3ng/ml; P= 0.577], Table 2, Figure 1. 
Table 2: Median (interquartile) of thyroid hormones and 25 (OH) 
vitamin D level in the cases and controls 
Variables  Cases (n= 58) Control (n= 58) P 
TSH ,miU/l 4.9 (2.0 ─ 9.5) 2.2 (1.1─ 3.4) < 0.001 
FT3, pmol/l 4.7 (3.8 ─ 5.4) 4.5 (3.9 ─ 5.3) 0.685 
FT4, pmol/l  13.3 (11.1─15.0) 14.0 (12.0─ 15.7) 0.028 
25 (OH) vitamin D, ng/ml  16.1(8.8─ 26.7) 14.0 (9.5─ 20.3) 0.577 
 
Linear regression showed no association 
between, age, BMI, haemoglobin, TSH, T3, T4 and 
the log of 25 (OH) vitamin D levels, Table3.  
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Figure 1: Median (interquartile) of 25 (OH) vitamin D level in the 
cases and the controls 
 
 
Discussion  
 
The main finding of the current study was a 
non-significant difference in the level of vitamin D 
among the women with hypothyroid compared to the 
control. This goes with Goswami et al., findings where 
they observed no significant difference between 
autoimmune thyroid disorders (AITD) and vitamin D 
levels [17]. Likewise, a non-significant association 
between vitamin D deficiency and autoimmune thyroid 
disorders (AITD) has been previously reported [18]. 
The aforementioned observation was further 
consolidated by a similar finding in hypothyroidism as 
the Hashimoto thyroiditis induced and Non-Hashimoto 
thyroiditis [18, 19].  
Table 3: Factors affecting log of 25 (OH) vitamin D level using 
multiple linear regression analysis 
Variables Coefficient Standard error P 
Age, years 0.003 0.003 0.189 
Body mass index, kg,m^2 0.002 0.005 0.608 
Haemoglobin, g/dl 0.013 0.021 0.525 
TSH, miU/l -0.002 0.008 0.814 
FT3, pmol/l
 0.000 0.034 0.998 
FT4, pmol/l − 0.001 0.011 0.913 
Case (hypothyroidism) versus controls 0.023 0.068 0.741 
 
The non-significant difference of low vitamin D 
level among both groups may be explained by the 
higher prevalence (61.5% to 83.6%) of vitamin D 
deficiency among Saudi population perhaps due and 
inadequate exposure to sensible sunlight or females 
are wearing black outer cloak which may reduce the 
benefit of sensible sunlight [20-22]. 
A significant correlation between vitamin D 
and hypothyroidism among female participants has 
recently been documented [23, 24]. Moreover, a 
recent study showed, the serum 25-OH vitamin D 
levels were significantly lower in a group of 
hypothyroid cases compared to healthy controls [25]. 
Some different studies documented a significant 
negative association between vitamin D levels in 
patients with Hashimoto's thyroiditis compared to the 
control group [1, 6, 26-31] 
 
Interestingly, significantly high levels of 
vitamin D were found in cases with subclinical 
hypothyroidism compared to a healthy control group in 
a similar study that was conducted in Saudi Arabia 
with the majority of cases being females: female (39) 
vs. males (3) [32]. 
The current study showed a significant 
difference in BMI between the cases and controls. 
This goes with one study conducted in the Kingdom of 
Saudi Arabia that showed similar findings [32]. In a 
similar context, another two studies proposed that 
vitamin D deficiency can predict BMI [33, 34].  
In this study, the median (interquartile) of 
serum thyroid stimulating hormone (TSH) levels and 
FT4 levels showed a significant difference between 
the two groups. This goes with the previous finding in 
one study that was conducted on the same nationality 
of participants [35]. Serum 25(OH)D levels were found 
to be significantly negatively correlated with serum 
thyroid stimulating hormone (TSH) levels and 
positively with T4 in some recent clinical data [36-38].  
The key role in the development of 
autoimmune process is genetically dependent on 
aberrant expression of HLA-DR and other antigens on 
the thyrocyte surface hence are become vulnerable to 
an autoimmune insult [39]. Likewise, a different gene 
in the Vitamin D receptor was found to be the culprit to 
autoimmune thyroid disease such as Graves’ disease 
and Hashimoto’s thyroiditis [26, 36]. An indirect effect 
can be due to a higher serum level of calcium, low 
level of circulating parathyroid hormone and high 
phosphorous levels which may lead to suppression of 
renal 25(OH) D1-α hydroxylase activity. Therefore 1, 
25 (OH) 2D productions will be reduced and this will 
be accompanied with marked elevation in both serum 
24, 25(OH) and serum thyroid hormone levels [6]. It 
has to be mentioned that the beneficial effects of 
vitamin D could be due to prevention/correction of the 
potential risk of hypothyroidism and an improvement 
in the thyroid functions [27, 40-42]. Also correction of 
vitamin D with anti-thyroid drugs or thyroid hormone 
replacement is associated with better treatment 
response, besides, suppressing the autoimmune 
reaction as reflected by reducing serum levels of 
thyroid autoantibodies [43]. Furthermore, vitamin D 
supplementation is associated with prevention and 
development of different autoimmune diseases in both 
humans and animal models [27]. Both vitamin D and 
thyroid hormone bind to analogous receptors called 
steroid hormone receptors. Tissues express vitamin D 
receptor (VDR) and 1-alpha-hydroxylase, have a 
paracrine and autocrine effects to allow upregulation 
of calcitriol production, neither depends on 
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parathormone nor renal influence. [6, 39] Mutation of 
genes encoding for tissue hydroxylases and VDR hire 
a risk for development of thyroid cancer. [44, 45] Low 
levels of vitamin D (1, 25-(OH) 2D3) were observed in 
different types of thyroid cancers and correlated with 
cancer staging (I-IV) [45]
 
On the other hand, low levels of vitamin D 
may be related to hypothyroidism disorder. We can 
justify the presence of low levels of vitamin D among 
subjects with hypothyroidism for poor intestinal 
absorption in some autoimmune disorders that are 
associated with hypothyroidism such as celiac 
disease and pernicious anaemia. Moreover, the 
seasonal variation may affect the prevalence as one 
report documented higher rates of low serum level of 
the vitamin during winter compared to spring [46]. The 
seasonal variation of vitamin D was not one of the 
objectives of the current study. On the contrary, a 
lower prevalence of vitamin D deficiency among 
males compared with females was previously 
observed, when gender issue was considered [22, 
36]. 
One of the limitations of this study is; calcium, 
phosphorous, parathyroid hormones and thyroid 
antibodies were not investigated. 
In conclusion, there was no significant 
difference in vitamin D level among females with 
hypothyroidism and healthy controls. 
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